
Fidelity Investments’s Ultragenyx Pharmaceutical RARE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $94.7M | Buy |
2,604,588
+2,223,166
| +583% | +$80.8M | 0.01% | 1141 |
|
2025
Q1 | $13.8M | Sell |
381,422
-14,562
| -4% | -$527K | ﹤0.01% | 1801 |
|
2024
Q4 | $16.7M | Sell |
395,984
-241,837
| -38% | -$10.2M | ﹤0.01% | 1788 |
|
2024
Q3 | $35.4M | Sell |
637,821
-9,797
| -2% | -$544K | ﹤0.01% | 1511 |
|
2024
Q2 | $26.6M | Sell |
647,618
-134,414
| -17% | -$5.52M | ﹤0.01% | 1547 |
|
2024
Q1 | $36.5M | Sell |
782,032
-210,919
| -21% | -$9.85M | ﹤0.01% | 1437 |
|
2023
Q4 | $47.5M | Sell |
992,951
-34,834
| -3% | -$1.67M | ﹤0.01% | 1312 |
|
2023
Q3 | $36.6M | Buy |
1,027,785
+195,108
| +23% | +$6.96M | ﹤0.01% | 1361 |
|
2023
Q2 | $38.4M | Sell |
832,677
-171,347
| -17% | -$7.9M | ﹤0.01% | 1375 |
|
2023
Q1 | $40.3M | Sell |
1,004,024
-75,050
| -7% | -$3.01M | ﹤0.01% | 1338 |
|
2022
Q4 | $50M | Buy |
1,079,074
+99,295
| +10% | +$4.6M | 0.01% | 1253 |
|
2022
Q3 | $40.6M | Sell |
979,779
-178,463
| -15% | -$7.39M | ﹤0.01% | 1329 |
|
2022
Q2 | $69.1M | Sell |
1,158,242
-97,282
| -8% | -$5.8M | 0.01% | 1119 |
|
2022
Q1 | $91.2M | Sell |
1,255,524
-35,855
| -3% | -$2.6M | 0.01% | 1105 |
|
2021
Q4 | $109M | Buy |
1,291,379
+130,394
| +11% | +$11M | 0.01% | 1067 |
|
2021
Q3 | $105M | Buy |
1,160,985
+286,371
| +33% | +$25.8M | 0.01% | 1086 |
|
2021
Q2 | $83.4M | Sell |
874,614
-2,900
| -0.3% | -$277K | 0.01% | 1200 |
|
2021
Q1 | $99.9M | Sell |
877,514
-193,985
| -18% | -$22.1M | 0.01% | 1066 |
|
2020
Q4 | $148M | Sell |
1,071,499
-98,600
| -8% | -$13.6M | 0.01% | 868 |
|
2020
Q3 | $96.2M | Sell |
1,170,099
-272,003
| -19% | -$22.4M | 0.01% | 923 |
|
2020
Q2 | $113M | Sell |
1,442,102
-333,608
| -19% | -$26.1M | 0.01% | 828 |
|
2020
Q1 | $78.9M | Sell |
1,775,710
-47,664
| -3% | -$2.12M | 0.01% | 847 |
|
2019
Q4 | $77.9M | Sell |
1,823,374
-260,247
| -12% | -$11.1M | 0.01% | 1018 |
|
2019
Q3 | $89.1M | Sell |
2,083,621
-207,667
| -9% | -$8.88M | 0.01% | 934 |
|
2019
Q2 | $145M | Sell |
2,291,288
-226,458
| -9% | -$14.4M | 0.02% | 769 |
|
2019
Q1 | $175M | Sell |
2,517,746
-429,178
| -15% | -$29.8M | 0.02% | 698 |
|
2018
Q4 | $128M | Sell |
2,946,924
-380,457
| -11% | -$16.5M | 0.02% | 742 |
|
2018
Q3 | $254M | Sell |
3,327,381
-131,704
| -4% | -$10.1M | 0.03% | 583 |
|
2018
Q2 | $266M | Sell |
3,459,085
-485,897
| -12% | -$37.4M | 0.03% | 553 |
|
2018
Q1 | $201M | Buy |
3,944,982
+303,061
| +8% | +$15.5M | 0.02% | 681 |
|
2017
Q4 | $169M | Sell |
3,641,921
-15,287
| -0.4% | -$709K | 0.02% | 761 |
|
2017
Q3 | $195M | Sell |
3,657,208
-147,017
| -4% | -$7.83M | 0.02% | 694 |
|
2017
Q2 | $236M | Sell |
3,804,225
-2,306,402
| -38% | -$143M | 0.03% | 615 |
|
2017
Q1 | $414M | Buy |
6,110,627
+227,802
| +4% | +$15.4M | 0.05% | 389 |
|
2016
Q4 | $414M | Sell |
5,882,825
-30,250
| -0.5% | -$2.13M | 0.06% | 370 |
|
2016
Q3 | $419M | Buy |
5,913,075
+65,292
| +1% | +$4.63M | 0.06% | 373 |
|
2016
Q2 | $286M | Buy |
5,847,783
+6,152
| +0.1% | +$301K | 0.04% | 519 |
|
2016
Q1 | $370M | Buy |
5,841,631
+18,689
| +0.3% | +$1.18M | 0.05% | 389 |
|
2015
Q4 | $653M | Buy |
5,822,942
+22,946
| +0.4% | +$2.57M | 0.09% | 232 |
|
2015
Q3 | $559M | Buy |
5,799,996
+419,169
| +8% | +$40.4M | 0.08% | 268 |
|
2015
Q2 | $551M | Buy |
5,380,827
+48,044
| +0.9% | +$4.92M | 0.07% | 309 |
|
2015
Q1 | $331M | Buy |
5,332,783
+551,363
| +12% | +$34.2M | 0.04% | 474 |
|
2014
Q4 | $210M | Buy |
4,781,420
+187,180
| +4% | +$8.21M | 0.03% | 653 |
|
2014
Q3 | $260M | Buy |
4,594,240
+85,347
| +2% | +$4.83M | 0.04% | 533 |
|
2014
Q2 | $125M | Buy |
4,508,893
+908,405
| +25% | +$25.1M | 0.02% | 881 |
|
2014
Q1 | $85.1M | Buy |
+3,600,488
| New | +$85.1M | 0.01% | 1068 |
|